The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

A vaccine to protect against the winter vomiting bug norovirus is set for a year-long trial by the UK’s National Health Service (NHS) after early results showed it creates a “strong immune response.” ...

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...